The Europe disposable endoscopes market size was exhibited at USD 777.25 million in 2024 and is projected to hit around USD 1628.96 million by 2034, growing at a CAGR of 7.68% during the forecast period 2024 to 2034.
Report Coverage | Details |
Market Size in 2025 | USD 836.94 Million |
Market Size by 2034 | USD 1628.96 Million |
Growth Rate From 2024 to 2034 | CAGR of 7.68% |
Base Year | 2024 |
Forecast Period | 2024-2034 |
Segments Covered | Type, End-use, Region |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Regional scope | Europe |
Key Companies Profiled | Olympus Corporation; Boston Scientific Corporation; PENTAX Medical (Hoya Corporation); FUJIFILM Holdings Corporation, Karl Storz GmbH & Co., KG; Stryker; Medtronic; Ambu A/S; STERIS plc. |
Growing preference to minimize the risk of infection and maximize better clinical outcomes has increased the adoption of disposable endoscopes and their accessories in Europe. Furthermore, the growing incidence of functional gastrointestinal disorders and several other chronic diseases such as diabetes, cancer, and cardiovascular disorders has increased the diagnosis rate over the years, which, in turn, is anticipated to boost the market growth. For instance, according to an article published by the European Commission in January 2024, in 29 European countries, an estimated 23.7 million individuals faced a cancer diagnosis in their lifetime.
Minimally invasive surgeries (MISs), utilizing small incisions for diagnosing and treating various conditions, are gaining widespread acceptance in this region. Surgeons are increasingly favoring endoscopic surgeries over conventional open surgeries due to their numerous benefits. Following are some of the benefits of minimally invasive surgeries,
Thus, such benefits offered by MISs boost the demand for disposable endoscopes.
Factors such as favorable reimbursement policies and commercialization of new products are anticipated to fuel market growth. Moreover, increasing CE mark approvals for disposable endoscopes and adopting various distribution strategies are major factors expected to boost the market. For instance, in November 2023, Ambu A/S received European regulatory clearance for its new ureteroscopy solution, such as Ambu aScope 5 Uretero, a flexible single-use ureteroscope.
The high prevalence of cancer & chronic diseases and the growing geriatric population are expected to drive the market growth in the country. According to Macmillan Cancer Support, in October 2022, there were approximately 3 million patients suffering from cancer in the UK, and 5.3 million patients are expected to be diagnosed with cancer in the country by 2040. The introduction of the National Awareness and Early Diagnosis Initiative has facilitated early diagnoses of cancer and increased access to optimal treatment, thereby playing a vital role in driving the market.
Recent technological advancements in disposable endoscopes have increased their demand in hospitals, diagnostic centers, and clinics, which is expected to drive the growth of the disposable endoscopes market. In addition, with various technological advancements, disposable endoscopy applications are widening at a rapid rate. For instance, different types of disposable endoscopes are available in the market and used in many specialties, including laparoscopy, ENT, arthroscopy, gynecology, urology, gastroenterology, and proctoscopy.
The adoption of disposable endoscopes increased due to their benefits, such as no maintenance costs, ready availability, no breakages, and no need for reprocessing between procedures. In addition, reprocessing reusable endoscopes is a challenge for many healthcare facilities. Multiple studies reported a high contamination rate after endoscope reprocessing, which further supports the adoption of disposable endoscopes. For instance, an article conducted study on duodenoscopes contamination published by The Journal of Hospital Infection in January 2023 reported that 27.5% of the reusable samples were positive for high-concern microorganisms.
The gastrointestinal endoscopes segment dominated the market with a revenue share of 56.8% in 2024. Gastrointestinal endoscopes are classified as lower or upper endoscopy, depending on the area to be treated, such as the upper gastrointestinal tract (stomach, esophagus, jejunum, and duodenum) or lower gastrointestinal tract (colon, rectum, and terminal ileum). The market is driven by technological advancements, a rising prevalence of gastrointestinal disorders, and a shift towards minimally invasive surgeries, and governments and health organizations have been encouraging routine screenings for cancer, increasing the demand for diagnostic procedures. For instance, according to World Cancer Research Fund International, approximately 62,544 individuals in Germany had colorectal cancer in 2022.
The Laparoscopes segment is expected to witness the fastest CAGR growth from 2024 to 2034. The growing prevalence of chronic diseases and conditions that require surgical intervention, such as obesity, appendicitis, gallbladder diseases, pelvic inflammatory disease, and cancers (ovarian cancer and liver cancer), fueled the demand for laparoscopic procedures. Furthermore, market players adopt various strategies to strengthen their product portfolio. For instance, in June 2023, STERIS plc signed a definitive agreement to purchase the laparoscopic instrumentation, sterilization container assets, and surgical instrumentation from BD (Becton, Dickinson, and Company) for USD 540 million.
The outpatient facilities segment dominated the market and accounted for the largest revenue share of 54.0% in 2024. This segment is anticipated to register the fastest growth over the forecast period. Outpatient facilities play an important role in the disposable endoscope market by offering efficient & convenient diagnostic and therapeutic procedures. The growing popularity of disposable endoscopes in outpatient settings is attributed to their multiple advantages. One of the major advantages of this endoscopes in outpatient facilities is their cost-effectiveness. These single-use endoscopes save time and resources for maintaining, sterilizing, and cleaning reusable endoscopes and eliminate the need for reprocessing. This streamlined approach reduces turnaround time, improves workflow efficiency, and enhances patient outcomes.
Hospital segment is anticipated to register a significant growth from 2024 to 2034. The rising number of healthcare centers, such as oncology specialty clinics, hospitals, and cancer centers, is growing the need for disposable endoscopes, which is anticipated to propel market growth. The number of endoscopies performed in hospitals is increasing with the rise in hospital facilities. For instance, the European Union has around 15,000 hospitals. Moreover, the UK has 1148 hospitals as of August 2023.
Europe Disposable Endoscopes Market Trends
Ongoing technological advancements in the endoscope field and a rise in demand for minimally invasive procedures are among the factors driving the European disposable endoscope market. In addition, the increasing number of endoscopic device manufacturers present in this region, and the rise in disposable endoscopic devices product development activities are driving the market in the region.
Denmark Disposable Endoscopes Market Trends
The disposable endoscopes market in Denmark held a significant share in 2024. Key market players are undertaking various initiatives to strengthen their position, further propelling market growth. For instance, in January 2022, Ambu introduced the aCart platform to promote the adoption of single-use endoscopes. The platform comprises two launches-aCart Compact and aCart Plus-which provide convenient storage & transportation for displaying units, endoscopes, and additional accessories. These carts are designed to be compatible with Ambu’s complete range of endoscopy products, aiming to enhance workflows in various healthcare settings, including endoscopy suites, intensive care units, and operating rooms.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the Europe disposable endoscopes market
Type
End-use
Regional
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. End Use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Europe Disposable Endoscopes Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.2.3. Industry challenges
3.3. Europe Disposable Endoscopes: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTLE Analysis
3.4. Reimbursement Framework
Chapter 4. Europe Disposable Endoscopes Market Segment Analysis, By Type, 2021-2034 (USD Million)
4.1. Definition and Scope
4.2. Type Market Share Analysis, 2024 & 2034
4.3. Segment Dashboard
4.4. Europe Disposable Endoscopes Market, by Type, 2018 to 2030
4.5. Laparoscopes
4.5.1. Laparoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Arthroscopes
4.6.1. Arthroscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Ureteroscopes
4.7.1. Ureteroscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.8. Cystoscopes
4.8.1. Cystoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.9. Gynecology Endoscopes
4.9.1. Gynecology Endoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.10. Neuroendoscopes Disposable Endoscopes
4.10.1. Neuroendoscopes estimates and forecasts, 2018 to 2030 (USD Million)
4.11. Hysteroscopes
4.11.1. Hysteroscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.12. Laryngoscopes
4.12.1. Laryngoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.13. Otoscopes
4.13.1. Otoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.14. Nasopharyngoscopes
4.14.1. Nasopharyngoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.15. Rhinoscopes
4.15.1. Rhinoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.16. Gastrointestinal Europe Disposable Endoscopes
4.16.1. Gastrointestinal Europe Disposable Endoscopes market estimates and forecasts, 2018 to 2030 (USD Million)
4.16.2. Gastroscope (Upper GI Endoscope)
4.16.2.1. Gastroscope (Upper GI Endoscope) market estimates and forecasts, 2018 to 2030 (USD Million)
4.16.3. Enteroscope
4.16.3.1. Enteroscope market estimates and forecasts, 2018 to 2030 (USD Million)
4.16.4. Duodenoscope
4.16.4.1. Duodenoscope market estimates and forecasts, 2018 to 2030 (USD Million)
4.16.5. Colonoscope
4.16.5.1. Colonoscope market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Europe Disposable Endoscopes Market Segment Analysis, By End Use, 2021-2034 (USD Million)
5.1. Definition and Scope
5.2. End Use Market Share Analysis, 2024 & 2034
5.3. Segment Dashboard
5.4. Europe Disposable Endoscopes Market, by End Use, 2018 to 2030
5.5. Hospitals
5.5.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Outpatient facilities
5.6.1. Outpatient facilities market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Region, By Product, By End Use, 2021 - 2034 (USD Million)
6.1. Regional Market Share Analysis, 2024 & 2034
6.2. Regional Market Dashboard
6.3. Regional Market Snapshot
6.4. Europe Disposable Endoscopes Market Share by Region, 2024 & 2034:
6.5. Europe
6.5.1. Europe endoscopy devices market, 2021 - 2034 (USD Million)
6.5.2. UK
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. UK endoscopy devices market, 2021 - 2034 (USD Million)
6.5.3. Germany
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. Germany endoscopy devices market, 2021 - 2034 (USD Million)
6.5.4. France
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. France endoscopy devices market, 2021 - 2034 (USD Million)
6.5.5. Italy
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. Italy endoscopy devices market, 2021 - 2034 (USD Million)
6.5.6. Spain
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Spain endoscopy devices market, 2021 - 2034 (USD Million)
6.5.7. Norway
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework/ reimbursement structure
6.5.7.3. Competitive scenario
6.5.7.4. Norway endoscopy devices market, 2021 - 2034 (USD Million)
6.5.8. Sweden
6.5.8.1. Key country dynamics
6.5.8.2. Regulatory framework/ reimbursement structure
6.5.8.3. Competitive scenario
6.5.8.4. Sweden endoscopy devices market, 2021 - 2034 (USD Million)
6.5.9. Denmark
6.5.9.1. Key country dynamics
6.5.9.2. Regulatory framework/ reimbursement structure
6.5.9.3. Competitive scenario
6.5.9.4. Denmark endoscopy devices market, 2021 - 2034 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company Categorization
7.3. Company Profiles
7.3.1. Olympus Corporation
7.3.1.1. Company overview
7.3.1.2. Financial performance
7.3.1.3. Product benchmarking
7.3.1.4. Strategic initiatives
7.3.2. Boston Scientific Corporation
7.3.2.1. Company overview
7.3.2.2. Financial performance
7.3.2.3. Product benchmarking
7.3.2.4. Strategic initiatives
7.3.3. PENTAX Medical (Hoya Corporation)
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Product benchmarking
7.3.3.4. Strategic initiatives
7.3.4. FUJIFILM Holdings Corporation
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Karl Storz GmbH & Co., KG
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Stryker
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Medtronic
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Ambu A/S.
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. STERIS plc.
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives